Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) Income from Continuing Operations (2016 - 2026)

Avanos Medical's Income from Continuing Operations history spans 13 years, with the latest figure at 1300000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 99.67% to 1300000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 72900000.0, a 81.13% increase, with the full-year FY2025 number at 72900000.0, up 81.13% from a year prior.
  • Income from Continuing Operations hit 1300000.0 in Q4 2025 for Avanos Medical, up from 1400000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for AVNS hit a ceiling of 38500000.0 in Q2 2021 and a floor of 397000000.0 in Q4 2024.
  • Historically, Income from Continuing Operations has averaged 23455000.0 across 5 years, with a median of 400000.0 in 2024.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 1383.33% in 2021 and later plummeted 3709.09% in 2024.
  • Tracing AVNS's Income from Continuing Operations over 5 years: stood at 25700000.0 in 2021, then skyrocketed by 137.74% to 9700000.0 in 2022, then increased by 13.4% to 11000000.0 in 2023, then plummeted by 3709.09% to 397000000.0 in 2024, then skyrocketed by 99.67% to 1300000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for AVNS at 1300000.0 in Q4 2025, 1400000.0 in Q3 2025, and 76800000.0 in Q2 2025.